Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.
Content published before 2002 is available via pay-per-view purchase only.
Subscribe:
Subscribe to Clinics in Laboratory MedicineAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- The landscape of somatic copy-number alteration across human cancers.Nature. 2010; 463: 899-905
- Pan-cancer patterns of somatic copy number alteration.Nat Genet. 2013; 45: 1134-1140
- Emerging landscape of oncogenic signatures across human cancers.Nat Genet. 2013; 45: 1127-1133
- Analysis of copy number variations in solid tumors using a next generation sequencing custom panel.J Mol Pathol. 2021; 2: 123-134
- Short- and long-term effects of chromosome mis-segregation and aneuploidy.Nat Rev Mol Cell Biol. 2015; 16: 473-485
- Tumor copy number alteration burden is a pan-cancer prognostic factor associated with recurrence and death.Elife. 2018; 7: e37294
- Copy number variation is highly correlated with differential gene expression: a pan-cancer study.BMC Med Genet. 2019; 20: 175
- Gastric cancer and gene copy number variation: emerging cancer drivers for targeted therapy.Oncogene. 2016; 35: 1475-1482
- Somatic gene copy number alterations in colorectal cancer: new quest for cancer drivers and biomarkers.Oncogene. 2016; 35: 2011-2019
- Copy-number analysis identified new prognostic marker in acute myeloid leukemia.Leukemia. 2017; 31: 555-564
- A minute chromosome in human chronic granulocytic leukemia.Science. 1960; : 1497
- Cytogenetic findings in liposarcoma correlate with histopathologic subtypes.Cancer. 1992; 69: 2484-2495
- Chromosome 3p loss–orchestrated VHL, HIF, and epigenetic deregulation in clear cell renal cell carcinoma.J Clin Oncol. 2018; 36: 3533-3539
- New comprehensive cytogenetic scoring system for primary myelodysplastic syndromes (MDS) and oligoblastic acute myeloid leukemia after MDS derived from an international database merge.J Clin Oncol. 2012; 30: 820-829
- Chromothripsis: a new mechanism for rapid karyotype evolution.Annu Rev Genet. 2015; 49: 183-211
- Extrachromosomal oncogene amplification in tumour pathogenesis and evolution.Nat Rev Cancer. 2019; 19: 283-288
- Section E6.1-6.4 of the ACMG technical standards and guidelines: chromosome studies of neoplastic blood and bone marrow-acquired chromosomal abnormalities.Genet Med. 2016; 18: 635-642
- Section E6.5-6.8 of the ACMG technical standards and guidelines: chromosome studies of lymph node and solid tumor-acquired chromosomal abnormalities.Genet Med. 2016; 18: 643-648
- Introduction.in: Wan T.S. Methods in. Cancer cytogenetics: methods and protocols. 220. Springer Protocols, 2016https://doi.org/10.1385/1-59259-363-1:001
Canadian College of Medical Geneticists (CCMG) Cytogenetics Committee. CCMG Practice Guidelines for Cytogenetic Analysis: Recommendations for the indications, analysis and reporting of cancer specimens. Published online 2010.
- Emerging molecular cytogenetic technologies.Cytobios. 1997; 90: 7-22
- Swerdlow S. Campo E. Harris N. WHO classification of tumours of haematopoietic and lymphoid tissues. Revised 4t. International Agency for Research on Cancer, 2017
- Fluorescence in situ hybridization for MDM2 amplification as a routine ancillary diagnostic tool for suspected well-differentiated and dedifferentiated liposarcomas: experience at a tertiary center.Sarcoma. 2015; : 812089
- Clinical significance of MYCN amplification in patients with high-risk neuroblastoma.Pediatr Blood Cancer. 2018; 65: e27257
- Association of MYCN copy number with clinical features, tumor biology, and outcomes in neuroblastoma: a report from the Children’s Oncology Group.Cancer. 2017; 123: 4224-4235
- Heterogeneous MYCN amplification in neuroblastoma: a SIOP europe neuroblastoma study.Br J Cancer. 2018; 118: 1502-1512
- Defining low-risk high hyperdiploidy in patients with paediatric acute lymphoblastic leukaemia: a retrospective analysis of data from the UKALL97/99 and UKALL2003 clinical trials.Lancet Haematol. 2021; 8: e828-e839
- Prevalence and timing of TP53 mutations in del(17p) myeloma and effect on survival.Blood Cancer J. 2017; 7: e610
- CDKN2A loss is associated with shortened overall survival in lower-grade (World Health Organization Grades II-III) astrocytomas.J Neuropathol Exp Neurol. 2015; 74: 442-452
- CDKN2A homozygous deletion is a strong adverse prognosis factor in diffuse malignant IDH-mutant gliomas.Neuro Oncol. 2019; 21: 1519-1528
- Molecular methods for genotyping complex copy number polymorphisms.Genomics. 2013; 101: 86-93
- Comparative Genomic Hybridization: microarray design and data interpretation.Methods Mol Biol. 2009; 529: 37-49
- The utilization of chromosomal microarray technologies for hematologic neoplasms: an ACLPS critical review.Am J Clin Pathol. 2018; 150: 375-384
- High resolution chromosomal microarray analysis (CMA) enhances the genetic profile of pediatric B-cell acute lymphoblastic leukemia patients.Leuk Res. 2019; 83: 106177
- The 2016 World health organization classification of tumors of the central nervous system: a summary.Acta Neuropathol. 2016; 131: 803-820
- Prognostic significance of relative 1p/19q codeletion in oligodendroglial tumors.J Neurooncol. 2015; 125: 249-251
- Adjuvant procarbazine, lomustine, and vincristine chemotherapy in newly diagnosed anaplastic oligodendroglioma: long-term follow-up of EORTC brain tumor group study 26951.J Clin Oncol. 2013; 31: 344-350
- Structural variation in the sequencing era.Nat Rev Genet. 2020; 21: 171-189
- Capmatinib in MET exon 14–mutated or MET -amplified non–small-cell lung cancer.N Engl J Med. 2020; 383: 944-957
- Histological specificity of alterations and expression of KIT and KITLG in non-small cell lung carcinoma.Genes Chromosom Cancer. 2013; 52: 1088-1096
- KIT as a therapeutic target in metastatic melanoma.JAMA. 2011; 305: 2327-2334
- Mechanisms of resistance to BRAF and MEK inhibitors and clinical update of us food and drug administration-approved targeted therapy in advanced melanoma.Onco Targets Ther. 2018; 11: 7095-7107
- Patient-centred outcomes and effect of disease progression on health status in patients with newly diagnosed advanced ovarian cancer and a BRCA mutation receiving maintenance olaparib or placebo (SOLO1): a randomised, phase 3 trial.Lancet Oncol. 2021; 22: 632-642
- Adjuvant olaparib for patients with BRCA1- or BRCA2-mutated breast cancer.N Engl J Med. 2021; 384: 2394-2405
- Pan-cancer analysis of BRCA1 and BRCA2 genomic alterations and their association with genomic instability as measured by genome-wide loss of heterozygosity.JCO Precis Oncol. 2020; : 442-465
- A new era of long-read sequencing for cancer genomics.J Hum Genet. 2020; 65: 3-10
- High-accuracy long-read amplicon sequences using unique molecular identifiers with Nanopore or PacBio sequencing.Nat Methods. 2021; 18: 165-169
- Copy-number variants in clinical genome sequencing: deployment and interpretation for rare and undiagnosed disease.Genet Med. 2019; 21: 1121-1130
- An evaluation of copy number variation detection tools for cancer using whole exome sequencing data.BMC Bioinformatics. 2017; 18: 1-13
- Accurate quantification of copy-number aberrations and whole-genome duplications in multi-sample tumor sequencing data.Nat Commun. 2020; 11https://doi.org/10.1038/s41467-020-17967-y
- Optical genome mapping as a next-generation cytogenomic tool for detection of structural and copy number variations for prenatal genomic analyses.Genes (Basel). 2021; 12: 1-11
- Advances in optical mapping for genomic research.Comput Struct Biotechnol J. 2020; 18: 2051-2062
- The clinical utility of optical genome mapping for the assessment of genomic aberrations in acute lymphoblastic leukemia.Cancers (Basel). 2021; 13: 4388
- Next-generation cytogenetics: comprehensive assessment of 52 hematological malignancy genomes by optical genome mapping.Am J Hum Genet. 2021; 108: 1423-1435
- Optical genome mapping, a promising alternative to gold standard cytogenetic approaches in a series of acute lymphoblastic leukemias.Genes Chromosomes Cancer. 2021; 60: 657-667
- Identification of somatic structural variants in solid tumors by optical genome mapping.J Pers Med. 2021; 11: 1-21
- Chromosomal microarray analysis, including constitutional and neoplastic disease applications, 2021 revision: a technical standard of the American College of Medical Genetics and Genomics (ACMG).Genet Med. 2021; https://doi.org/10.1038/s41436-021-01214-w
- Technical laboratory standards for interpretation and reporting of acquired copy-number abnormalities and copy-neutral loss of heterozygosity in neoplastic disorders: a joint consensus recommendation from the American College of Medical Genetics and Genom.Genet Med. 2019; 21: 1903-1915
- EGFR-L858R mutant enhances lung adenocarcinoma cell invasive ability and promotes malignant pleural effusion formation through activation of the CXCL12-CXCR4 pathway.Sci Rep. 2015; 5: 1-14
- Prognostic significance of activating FLT3 mutations in younger adults (16 to 60 years) with acute myeloid leukemia and normal cytogenetics: a study of the AML study group Ulm.Blood. 2002; 100: 4372-4380
- Inherited and acquired alterations in development of breast cancer.Appl Clin Genet. 2011; 4: 145-158
- ERBB2 amplification in breast cancer analyzed by fluorescence in situ hybridization.Proc Natl Acad Sci U S A. 1992; 89: 5321-5325
- The prognostic impact of 17p (p53) deletion in 2272 adults with acute myeloid leukemia.Leukemia. 2009; 23: 656-663
- Adult low-hypodiploid acute B-lymphoblastic leukemia with IKZF3 deletion and TP53 mutation: comparison with pediatric patients.Am J Clin Pathol. 2015; 144: 263-270
- The impact of tumor heterogeneity on diagnostics and novel therapeutic strategies in multiple myeloma.Int J Mol Sci. 2019; 20: 1248
- Comprehensive analysis of chromothripsis in 2,658 human cancers using whole-genome sequencing.Nat Genet. 2020; 52: 331-341
Article info
Publication history
Published online: August 22, 2022
Identification
Copyright
Crown Copyright © 2022 Published by Elsevier Inc. All rights reserved.
